Cargando…

Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis

Cytokines, demyelination and neuroaxonal degeneration in the central nervous system are pivotal elements implicated in the pathogenesis of multiple sclerosis (MS) and its nonclinical model of experimental autoimmune encephalomyelitis (EAE). Phycocyanobilin (PCB), a chromophore of the biliprotein C-P...

Descripción completa

Detalles Bibliográficos
Autores principales: Marín-Prida, Javier, Pavón-Fuentes, Nancy, Lagumersindez-Denis, Nielsen, Camacho-Rodríguez, Hanlet, García-Soca, Ana Margarita, Sarduy-Chávez, Rocío de la Caridad, Vieira, Érica Leandro Marciano, Carvalho-Tavares, Juliana, Falcón-Cama, Viviana, Fernández-Massó, Julio Raúl, Hernández-González, Ignacio, Martínez-Donato, Gillian, Guillén-Nieto, Gerardo, Pentón-Arias, Eduardo, Teixeira, Mauro Martins, Pentón-Rol, Giselle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669316/
https://www.ncbi.nlm.nih.gov/pubmed/36405721
http://dx.doi.org/10.3389/fimmu.2022.1036200
_version_ 1784832071509737472
author Marín-Prida, Javier
Pavón-Fuentes, Nancy
Lagumersindez-Denis, Nielsen
Camacho-Rodríguez, Hanlet
García-Soca, Ana Margarita
Sarduy-Chávez, Rocío de la Caridad
Vieira, Érica Leandro Marciano
Carvalho-Tavares, Juliana
Falcón-Cama, Viviana
Fernández-Massó, Julio Raúl
Hernández-González, Ignacio
Martínez-Donato, Gillian
Guillén-Nieto, Gerardo
Pentón-Arias, Eduardo
Teixeira, Mauro Martins
Pentón-Rol, Giselle
author_facet Marín-Prida, Javier
Pavón-Fuentes, Nancy
Lagumersindez-Denis, Nielsen
Camacho-Rodríguez, Hanlet
García-Soca, Ana Margarita
Sarduy-Chávez, Rocío de la Caridad
Vieira, Érica Leandro Marciano
Carvalho-Tavares, Juliana
Falcón-Cama, Viviana
Fernández-Massó, Julio Raúl
Hernández-González, Ignacio
Martínez-Donato, Gillian
Guillén-Nieto, Gerardo
Pentón-Arias, Eduardo
Teixeira, Mauro Martins
Pentón-Rol, Giselle
author_sort Marín-Prida, Javier
collection PubMed
description Cytokines, demyelination and neuroaxonal degeneration in the central nervous system are pivotal elements implicated in the pathogenesis of multiple sclerosis (MS) and its nonclinical model of experimental autoimmune encephalomyelitis (EAE). Phycocyanobilin (PCB), a chromophore of the biliprotein C-Phycocyanin (C-PC) from Spirulina platensis, has antioxidant, immunoregulatory and anti-inflammatory effects in this disease, and it could complement the effect of other Disease Modifying Treatments (DMT), such as Interferon-β (IFN-β). Here, our main goal was to evaluate the potential PCB benefits and its mechanisms of action to counteract the chronic EAE in mice. MOG(35-55)-induced EAE was implemented in C57BL/6 female mice. Clinical signs, pro-inflammatory cytokines levels by ELISA, qPCR in the brain and immunohistochemistry using precursor/mature oligodendrocytes cells antibodies in the spinal cord, were assessed. PCB enhanced the neurological condition, and waned the brain concentrations of IL-17A and IL-6, pro-inflammatory cytokines, in a dose-dependent manner. A down- or up-regulating activity of PCB at 1 mg/kg was identified in the brain on three (LINGO1, NOTCH1, and TNF-α), and five genes (MAL, CXCL12, MOG, OLIG1, and NKX2-2), respectively. Interestingly, a reduction of demyelination, active microglia/macrophages density, and axonal damage was detected along with an increase in oligodendrocyte precursor cells and mature oligodendrocytes, when assessed the spinal cords of EAE mice that took up PCB. The studies in vitro in rodent encephalitogenic T cells and in vivo in the EAE mouse model with the PCB/IFN-β combination, showed an enhanced positive effect of this combined therapy. Overall, these results demonstrate the anti-inflammatory activity and the protective properties of PCB on the myelin and support its use with IFN-β as an improved DMT combination for MS.
format Online
Article
Text
id pubmed-9669316
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96693162022-11-18 Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis Marín-Prida, Javier Pavón-Fuentes, Nancy Lagumersindez-Denis, Nielsen Camacho-Rodríguez, Hanlet García-Soca, Ana Margarita Sarduy-Chávez, Rocío de la Caridad Vieira, Érica Leandro Marciano Carvalho-Tavares, Juliana Falcón-Cama, Viviana Fernández-Massó, Julio Raúl Hernández-González, Ignacio Martínez-Donato, Gillian Guillén-Nieto, Gerardo Pentón-Arias, Eduardo Teixeira, Mauro Martins Pentón-Rol, Giselle Front Immunol Immunology Cytokines, demyelination and neuroaxonal degeneration in the central nervous system are pivotal elements implicated in the pathogenesis of multiple sclerosis (MS) and its nonclinical model of experimental autoimmune encephalomyelitis (EAE). Phycocyanobilin (PCB), a chromophore of the biliprotein C-Phycocyanin (C-PC) from Spirulina platensis, has antioxidant, immunoregulatory and anti-inflammatory effects in this disease, and it could complement the effect of other Disease Modifying Treatments (DMT), such as Interferon-β (IFN-β). Here, our main goal was to evaluate the potential PCB benefits and its mechanisms of action to counteract the chronic EAE in mice. MOG(35-55)-induced EAE was implemented in C57BL/6 female mice. Clinical signs, pro-inflammatory cytokines levels by ELISA, qPCR in the brain and immunohistochemistry using precursor/mature oligodendrocytes cells antibodies in the spinal cord, were assessed. PCB enhanced the neurological condition, and waned the brain concentrations of IL-17A and IL-6, pro-inflammatory cytokines, in a dose-dependent manner. A down- or up-regulating activity of PCB at 1 mg/kg was identified in the brain on three (LINGO1, NOTCH1, and TNF-α), and five genes (MAL, CXCL12, MOG, OLIG1, and NKX2-2), respectively. Interestingly, a reduction of demyelination, active microglia/macrophages density, and axonal damage was detected along with an increase in oligodendrocyte precursor cells and mature oligodendrocytes, when assessed the spinal cords of EAE mice that took up PCB. The studies in vitro in rodent encephalitogenic T cells and in vivo in the EAE mouse model with the PCB/IFN-β combination, showed an enhanced positive effect of this combined therapy. Overall, these results demonstrate the anti-inflammatory activity and the protective properties of PCB on the myelin and support its use with IFN-β as an improved DMT combination for MS. Frontiers Media S.A. 2022-11-03 /pmc/articles/PMC9669316/ /pubmed/36405721 http://dx.doi.org/10.3389/fimmu.2022.1036200 Text en Copyright © 2022 Marín-Prida, Pavón-Fuentes, Lagumersindez-Denis, Camacho-Rodríguez, García-Soca, Sarduy-Chávez, Vieira, Carvalho-Tavares, Falcón-Cama, Fernández-Massó, Hernández-González, Martínez-Donato, Guillén-Nieto, Pentón-Arias, Teixeira and Pentón-Rol https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Marín-Prida, Javier
Pavón-Fuentes, Nancy
Lagumersindez-Denis, Nielsen
Camacho-Rodríguez, Hanlet
García-Soca, Ana Margarita
Sarduy-Chávez, Rocío de la Caridad
Vieira, Érica Leandro Marciano
Carvalho-Tavares, Juliana
Falcón-Cama, Viviana
Fernández-Massó, Julio Raúl
Hernández-González, Ignacio
Martínez-Donato, Gillian
Guillén-Nieto, Gerardo
Pentón-Arias, Eduardo
Teixeira, Mauro Martins
Pentón-Rol, Giselle
Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis
title Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis
title_full Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis
title_fullStr Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis
title_full_unstemmed Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis
title_short Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis
title_sort anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: a therapeutic promise for multiple sclerosis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669316/
https://www.ncbi.nlm.nih.gov/pubmed/36405721
http://dx.doi.org/10.3389/fimmu.2022.1036200
work_keys_str_mv AT marinpridajavier antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis
AT pavonfuentesnancy antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis
AT lagumersindezdenisnielsen antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis
AT camachorodriguezhanlet antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis
AT garciasocaanamargarita antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis
AT sarduychavezrociodelacaridad antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis
AT vieiraericaleandromarciano antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis
AT carvalhotavaresjuliana antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis
AT falconcamaviviana antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis
AT fernandezmassojulioraul antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis
AT hernandezgonzalezignacio antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis
AT martinezdonatogillian antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis
AT guillennietogerardo antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis
AT pentonariaseduardo antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis
AT teixeiramauromartins antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis
AT pentonrolgiselle antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis